Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1998-02-12
1999-10-26
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514159, 514178, 514180, 514181, 514188, 514762, 424702, 424705, A61K 3156, A61K 3160, A61K 31555, A61K 3304
Patent
active
059729201
ABSTRACT:
One or more formulations for treating psoriasis and other skin disorders characterized by redness, itching, flaking, scaling, and plaque-type growth. The formulation includes a carrier component, one or more active ingredient components, and a surfactant component. The carrier preferably includes an alcohol in substantially equal volume with isopropyl myristate. The active ingredient component preferably includes a superpotent or high-potency corticosteroid such as clobetasol propionate, an anti-flaking ingredient such as zinc pyrithione, or a combination of the two. It may also include an anti-fungal compound. The surfactant component preferably includes an alkyl sulfate such as sodium lauryl sulfate. The formulations made by applied topically either in spray form or as a direct-contact liquid.
REFERENCES:
patent: 3730182 (1973-05-01), Boghosian
patent: 4424234 (1984-01-01), Alderson et al.
patent: 4686211 (1987-08-01), Hara et al.
Atwood Pierce
Caseiro Chris A.
Dermalogix Partners, Inc.
Jarvis William R. A.
LandOfFree
Formulation containing a carrier, active ingredient, and surfact does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulation containing a carrier, active ingredient, and surfact, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation containing a carrier, active ingredient, and surfact will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-764709